SCHEMBL52492

SCHEMBL52492

O=C(NCc1ccc(F)cc1)c1nc2n(c(=O)c1O)CC1CCC2(N(Cc2ccccc2)C(=O)O)CC1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.46
CYP2C9 P11712 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ERCC1 P07992 1/20 0.39
FEN1 P39748 1/20 0.39
ERCC4 Q92889 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
ALDH1A1 P00352 2/20 0.37
CALCA P06881 1/20 0.37
OPRL1 P41146 2/20 0.37
KCNE1 P15382 1/20 0.36
CCR1 P32246 1/20 0.36
KCNQ1 P51787 1/20 0.36
THRB P10828 1/20 0.36
TSHR P16473 1/20 0.36
GAA P10253 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL52461 0.91 KCNH2 (0.49) KCNH2CYP2C9SMN1; SMN2L3MBTL1ERCC1
SCHEMBL51956 0.88 KCNH2 (0.45) KCNH2CYP2C9SMN1; SMN2L3MBTL1ERCC1
SCHEMBL52210 0.88 KCNH2 (0.51) KCNH2CYP2C9SMN1; SMN2L3MBTL1ERCC1
SCHEMBL52222 0.87 KCNH2 (0.54) KCNH2CYP2C9SMN1; SMN2L3MBTL1ERCC1
SCHEMBL52281 0.87 KCNH2 (0.43) KCNH2CYP2C9SMN1; SMN2L3MBTL1ERCC1
SCHEMBL52253 0.86 KCNH2 (0.49) KCNH2CYP2C9SMN1; SMN2L3MBTL1ERCC1
SCHEMBL418769 0.85 KCNH2 (0.48) KCNH2CYP2C9SMN1; SMN2L3MBTL1ERCC1
SCHEMBL422080 0.85 KCNH2 (0.50) KCNH2CYP2C9SMN1; SMN2L3MBTL1ERCC1
SCHEMBL62514 0.84 CYP2C9 (0.56) KCNH2CYP2C9SMN1; SMN2L3MBTL1ERCC1
SCHEMBL63268 0.84 KCNH2 (0.53) KCNH2CYP2C9SMN1; SMN2L3MBTL1ERCC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2280981-B1 BRIDGED HETEROCYCLES AS HIV INTEGRASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2014-04-23 EP disclosed
EP-2280981-A1 BRIDGED HETEROCYCLES AS HIV INTEGRASE INHIBITORS Bristol-Myers Squibb Company (US) 2011-02-09 EP disclosed